The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 30th Apr 2012 08:29

Anglo American: AlphaValue downgrades from neutral to reduce, target cut from 7,115p to 6,970p.AstraZeneca: Jefferies upgrades from hold to buy, target cut from 3,050p to 2,975p; JP Morgan Cazenove upgrades from underweight to neutral, target hiked from 2,800p to 3,050p.British Sky Broadcasting: Citigroup upgrades from neutral to buy.Carphone Warehouse: UBS slashes target from 208p to 170p, buy recommendation unchanged.CSR: Jefferies keeps buy rating and 290p target.Daisy Group: Jefferies cuts target from 145p to 140p, buy rating kept.Fenner: Jefferies reiterates buy recommendation and 565p target.Fidessa: Jefferies maintains undeperform rating and 1,300p target; finnCap upgrades from sell to hold.Hikma: Jefferies maintains buy rating and 860p target.Morgan Crucible: Jefferies upgrades from hold to buy, target lifted from 300p target 365p.Ophir Energy: Jefferies keeps buy rating and 555p target.Randgold Resources: Nomura downgrades from neutral to reduce, target cut from 7,115p to 6,970p.Severn Trent: Investec downgrades from buy to hold.Spirent Communications: Jefferies initiates coverage with buy recommendation and 199p target.WPP: Nomura ups target from 1,020p to 1,030p, buy rating unchanged.BC

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.